ALLE LÄNDER

1

High-Impact Cancer Research

29. Okt 2018 - 26. Okt 2019 • Boston, Vereinigte Staaten

Zusammenfassung:

In this special program, world leaders in cancer research from Harvard and other internationally recognized institutes share their insights, and participants learn the new fundamentals of a wide spectrum of cancer science. You will gain the skills necessary to envision, design, and lead cutting-edge cancer research projects that can contribute to the diagnosis, prevention, and treatment of cancer. This year-long program is designed to help participants make high-impact contributions that lead to better cancer outcomes.

The Scientific Committee invites all researchers, academicians, students and business professionals in the field of cancer science to submit high-quality articles to The International Conference on Cancer Research (ICCR 2019) which will be held on 5th – 6th April 2019. Articles must be submitted online through the conference submission system on the official website:

The Department of Biochemistry at Stellenbosch University has a long history in steroid research and we are excited to welcome both our local and international colleagues to our institution located in the world-famous winelands of Stellenbosch. The conference coincides with the centenary of Stellenbosch University and forms part of our celebrations. In addition, the conference precedes the 18th International Congress of Endocrinology, which will be held at the Cape Town Convention Centre, Cape Town, South Africa, from 1-4 December 2018. The objective of this conference is to promote interaction and discussion within the field of steroid hormones and hormone-dependent cancers.

The Miami Brain Symposium will focus on state-of-the-art approaches in the management of primary and metastatic brain tumors, along with an understanding of current standards of care as well as a look at future directions. For one full day this symposium will engage participants, as the expert faculty navigate through complex cases and novel treatment strategies and lively panel discussions.

The conference is for all practicing medical oncologists and trainees involved in the management of pancreatic cancer. There will be a unique opportunity for trainees to have a dialogue with key opinion leaders in the field, in order to improve their understanding about the complexity and management of this disease.

The aim of our meeting is to provide an update on what is new, clinically relevant and indeed controversial in the management of patients with thyroid cancer. We have selected what we believe to be some of the most important current issues for discussion and we have asked experts from the UK and distinguished guest speakers from abroad.

The success of immunotherapy in the treatment of cancer patients has proved the long-standing hypothesis that endogenous adaptive immune responses against the tumor can be harnessed to mediate protection by immune checkpoint blockade. This approach has shown impressive control of disease and improved survival in up to 50% of patients with certain tumors. Genetic and immune analysis of human cancers suggests that one mechanism of resistance to immune checkpoint blockade may be due to lack of tumor-specific T cells. In principle, vaccines have the potential to overcome this defect by either expanding low-level existing tumor-specific T cell responses or priming tumor-specific T cells. Recent advances in next-generation sequencing have improved our understanding of defining cancer antigens. Application of this will require vaccine delivery approaches that can induce potent and broad T cell immunity in an efficient manner for personalized therapy. This Keystone Symposia conference will highlight recent insights in the characterization of immunogenic cancer antigens, the biology and underlying mechanisms of T cell priming, and the development of novel approaches designed to expand T cell responses. Part of the meeting will also be devoted to the development of technologies to monitor T cell responses in response to immune interventions.

The conference consists of three modules, basic bronchoscopy, advanced diagnostic bronchoscopy and advanced interventional bronchoscopy. The basic course is intended for doctors who are training in respiratory medicine, cardio-thoracic surgery and anaesthetists. The key areas covered in the advanced diagnostic module will be assessment and staging of lung cancer and diagnosis of peripheral nodules with the use of endobronchial ultrasound and magnetic navigation guided bronchoscopy. The advanced interventional course will cover theoretical aspects around the relevant procedures, some hands-on simulators and video demonstrations.

Essential Oils for Rest, recovery and repair in cancer and palliative care

01. Feb 2019 • London, Großbritannien

Zusammenfassung:

This class is designed for therapists working in cancer care, palliative care or other clinical settings who are looking to improve efficiency when working with patients that have sleep disturbance and or fatigue related to their personal journal with a potentially life limiting disease, its treatment and its impact on the body and mind.

The first EACR conference on Tracking Cancer will highlight the newest approaches to cancer detection and monitoring, from diagnosis through therapy and progression. It will be an interactive environment to discuss current challenges and ways to move the field forward. The meeting will foster the exchange of ideas and spur multidisciplinary collaborations. The programme includes multiple opportunities for networking and interaction. As well as the lively poster sessions, there will be Panel Discussions at the end of each day for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving technologies into basic, translational and clinical cancer research. Charles Sawyers (MSKCC), Lillian Siu (Princess Margaret Cancer Centre) and Caroline Dive (CRUK Manchester Institute) will give keynote lectures.

Welcome to the 2019 HCC Summit, the home of liver cancer research, which will address the latest developments in hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) that you as a practicing physician and/or scientist should know.

Defect in DNA damage repair and checkpoint control is the underlying mechanism for tumorigenesis, since it allows the accumulation of multiple genetic alternations, which are essential for the initiation of tumorigenesis.

The AEK Cancer Congress is a medium size conference with around 500 participants. It is funded by the German Cancer Society (this time with additional support of the German Research Foundation) and will be held in 2019 under the theme “Translating Cancer Biology: From Basic Mechanism to Therapeutic Exploitation”.

Cancer immunotherapy is now an established field that has led to remarkable clinical benefit for a subset of patients. However, a deeper understanding of the mechanisms of response and resistance to current immunotherapy strategies is needed to help develop new treatments that will increase the number of patients who will benefit. This conference will explore mechanisms related to response and resistance, including novel methodologies to identify these mechanisms, and provide insights into new targets and combinatorial therapies that are being developed.

In this conference, we will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy. Richard Flavell (Yale University School of Medicine), Laurence Zitvogel (Gustave Roussy) and George Coukos (Ludwig Institute for Cancer Research) will give keynote lectures.

Proventa International’s unique format of Oncology Strategy Meeting Europe 2019 gathers seasoned local and global thought leaders in an exclusive discussion where director-level professionals share knowledge and insights on key strategic challenges. This year's Oncology Strategy Meeting will be held at The Westin Grand Munich, Germany on March 13, 2019.

Everything you ever wanted to know about: The Role of Radiology in cancer diagnosis and treatment

16. Mär 2019 • London, Großbritannien

Zusammenfassung:

This one day course is aimed at all radiographers, nurses, doctors and all other clinicians wanting to know more about the role of imaging in cancer care. This study day will provide a greater understanding of the role of radiology in the diagnosis and treatment of cancers and the role that diagnostic imaging plays within this

ASCCP2019 Annual Scientific Meeting on Anogenital and HPV-Related Diseases will feature a variety of topics including: Barriers to Care (transgender, homeless, incarcerated, mentally ill, as well as age and obesity), Patient-Centered Counseling Techniques, for Discussing Risk and Disease State Concepts, Research Ethics and At-Risk Populations, Cervical Cancer Screening Guidelines – U.S. and Beyond, ASCCP Colposcopy Standards with Cases, Risk-Based Assessment and Management, As well as specific sessions to review topics in Anal Diseases, Vulvar Diseases, and Transgender Care.

3rd International Cancer Conference and Expo welcomes you as our guest to the City of Baltimore, USA during June 05-07, 2019. This 3rd International Cancer Conference and Expo aims in Driving Innovative Cancer Science Towards Precision Medicine. iCancer USA includes nearly every permutation of knowledge, innovation, technology and networking; and has an objective of creating an international forum for academicians, practitioners and business professionals to discuss the soundest issues related to Cancer, Biotech and Health Care.

Sciinov invites all the participants from all over the world to attend "Global Conference on Oncology and Radiology" going to be held in Rome, Italy during 27-28, May 2019. GCOR-Rome includes prompt keynote presentations, Oral talks, Poster presentations, Workshops, Symposiums and Exhibitions.

New diagnostic technologies and therapeutic approaches are being developed and implemented which will transform patient management in the near future. As with the previous two meetings, this conference will include academic scientists and industry.

3rd International Cancer Conference and Expo welcomes you as our guest to the City of Baltimore, USA during June 05-07, 2019. iCancer USA 2019 aims in "Driving Innovative Cancer Science Towards Precision Medicine". This conference provides a forum for exchange of ideas and authoritative views by eminent personalities in this exciting field, by bringing together Cancer Science, Drug Development, Nanotechnology in Cancer Treatment, Robotic Surgery, Therapies, Oncology, Clinical trials, Cancer imaging, Medical radiation, Cancer detection, Control and Prevention research professionals; Academicians, Doctors, Study sponsors, Related Associations & Societies; Executives from Bio-Engineering, Diagnosis Tools, Medical devices and Pharmaceutical industries around the globe. iCancer USA 2019 offers unparalleled business, research opportunities and access to new markets in Cancer and Health Care industry. Be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest. Join us and witness the booming industry by participating at iCancer USA 2019 and give your career and business access to new opportunities from throughout the world.

Cancer Genomics 2019 is the fourth EACR conference on this topic, and it is now widely recognised as the premier European conference dedicated to cancer genomics. In 2019 it will again cover the latest exciting developments: convergence (modelling, artificial intelligence and big data), single cell analysis of cancers, cancer immune genomics, and clinical applications of genomics.

ICAHO19 — The 7th International Conference on Advances in Hematology and Oncology

29. Jun 2019 - 30. Jun 2019 • Seattle, Vereinigte Staaten

Zusammenfassung:

The 7th International Conference on Advances in Hematology and Oncology (#ICAHO19) is the premier Hematology/Oncology conference organized by the Binaytara Foundation in the Pacific Northwest. This year, ICAHO will be held in Seattle, Washington at the Crowne Plaza Downtown on June 29-30, 2019. It is designed to update healthcare professionals on the latest research and guidelines in the field. Like previous years, ICAHO19 will feature renowned faculties who will discuss about recent updates in Hematology and Oncology including a review of the 2019 ASCO® Annual Meeting.

This meeting aims to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse. It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice.

ABC has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of advanced breast cancer patients. These treatment guidelines are based on the most up-to-date evidence and can be used and adapted to many different health care settings globally.